Evidence map›Paper›PMID 40136351›Full record

ArticleCurrent oncology (Toronto, Ont.)2025

COVID-19 Pandemic Impact on Delays in Diagnosis and Treatment for Cervical Cancer in Montreal, Canada.

Yohan Kerbage, Elise Hillmann, Jessica Ruel-Laliberté, Vanessa Samouelian

Abstract read
In one paragraph

Article in Current oncology (Toronto, Ont.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yohan KerbageService de Chirurgie Gynécologique, CHU Lille, University Lille, 1 Avenue Oscar Lambret, F-59000 Lille, France.
Elise HillmannCentre de Recherche du CHUM (CRCHUM), Montréal, QC H2X 0A9, Canada.
Jessica Ruel-LalibertéGynecologic Oncology Division, Centre Hospitalier de l'Université de Sherbrooke (CHUS), Sherbrooke, QC J1H 5N4, Canada.ORCID 0000-0002-6108-838X
Vanessa SamouelianCentre de Recherche du CHUM (CRCHUM), Montréal, QC H2X 0A9, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe COVID-19 pandemic has been responsible for a major reorganization of healthcare systems, with less access for cancer screening. Few data exist on the impact of cervical cancer treatment during the pandemic.

methodsThe purpose of this study was to compare the cervical cancer stage at diagnosis and the surgical and medical treatment delays before and during the COVID-19 pandemic. This is a retrospective cohort study of all cervical cancers diagnosed at any stages between 1 January 2018 and 28 February 2022 at the Centre Hospitalier de l'Université de Montréal. Stage at diagnosis, time to initial referral, time from diagnosis to treatment before and during the COVID-19 pandemic were compared.

resultsA total of 244 cervical cancers were diagnosed during the study period. No differences were observed between the number of cases diagnosed before and after pandemic (

Indexed as

COVID-19Delayed DiagnosisTime-to-TreatmentUterine Cervical NeoplasmsAdultAgedFemaleHumansMiddle AgedNeoplasm StagingPandemicsQuebecRetrospective StudiesSARS-CoV-2cervical cancerCOVID-19pandemictreatments delayvolume reduction

Identifiers

PMID40136351
PMCPMC11941124

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.